CLINICAL_TRIALS
trial_result
· 2024-09-19
Clinical Trial Update: The Purpose of the Study is to Continue to Provide Pemigatinib to Patients With Advanced Malignancies. [Phase 2]
Summary
The Phase 2 pemigatinib trial in patients with advanced malignancies has been terminated, and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Incyte Corporation | Conditions: Advanced Malignancies | Phase 2 | Status: TERMINATED | Results posted: 2024-09-19